10/28/2024

0.45% Sodium Chloride Injection Bags

Products Affected - Description

- 0.45% Sodium Chloride injection, BBraun, 1000 mL PVC/DEHP-free bag, 12 count, NDC 00264-7802-00
- 0.45% Sodium Chloride injection, BBraun, 500 mL PVC/DEHP-free bag, 24 count, NDC 00264-7802-10
- 0.45% Sodium Chloride injection, Baxter, 1000 mL bag, 14 count, NDC 00338-0043-04
- 0.45% Sodium Chloride injection, Baxter, 500 mL bag, 24 count, NDC 00338-0043-03
- 0.45% Sodium Chloride injection, Fresenius Kabi, 1,000 mL freeflex bag, 10 count, NDC 63323-0626-10
- 0.45% Sodium Chloride injection, Fresenius Kabi, 250 mL freeflex bag, 30 count, NDC 63323-0626-25
- 0.45% Sodium Chloride injection, Fresenius Kabi, 250 mL freeflex+ bag, 30 count, NDC 63323-0230-25
- 0.45% Sodium Chloride injection, Fresenius Kabi, 500 mL freeflex bag, 20 count, NDC 63323-0626-55
- 0.45% Sodium Chloride injection, Fresenius Kabi, 500 mL freeflex+ bag, 20 count, NDC 63323-0232-50
- 0.45% Sodium Chloride injection, ICU Medical, 1000 mL bag, 12 count, NDC 00990-7985-09
- 0.45% Sodium Chloride injection, ICU Medical, 250 mL bag, 24 count, NDC 00990-7985-02
- 0.45% Sodium Chloride injection, ICU Medical, 500 mL bag, 24 count, NDC 00990-7985-03

Reason for the Shortage

- Baxter has sustained damage to their North Cove plant that supplies large volume fluids.

Estimated Resupply Dates

- All marketed presentations are on allocation or back order.

Safety

- FDA has authorized Baxter to extend the use dates of multiple product codes without relabeling the products. The following link provides the product codes and expiration dates: https://meded.baxter.com/sites/g/files/ebysai4096/files/2024-10/ExtendedExpDatesIVSolutions%20v2.pdf

Alternative Agents & Management

- See ASHP Suggestions for Management and Conservation during Fluid Shortages at https://www.ashp.org/drug-shortages/shortage-resources/publications/fluid-shortages-suggestions-for-management-and-conservation

Updated

Updated October 28, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 7, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.